Pathology and Molecular Biology of Melanoma
Article in Current Issues in Molecular Biology (June 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study
Article in Frontiers in Oncology (February 2023)
Clinical cancer immunotherapy: Current progress and prospects
Article in Frontiers in Immunology (October 2022)